Inventor

MYLARI BANAVARA L

US56 patents

⚠️ This page may combine multiple inventors who share the name “MYLARI BANAVARA L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MYLARI BANAVARA L

PFIZER

Sorbitol dehydrogenase inhibitors

Pyridazinone aldose reductase inhibitors

Compounds for treating and preventing diabetic complications

Heterocyclic oxophthalazinyl acetic acids

Substituted pyridmidines for control of diabetic complications

Substituted pyrimidines for control of diabetic complications

Pyridazinone aldose reductase inhibitors

Combination of gaba agonists and aldose reductase Inhibitors

Salts of zopolrestat

Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors

Combination of gaba agonists and sorbitol dehydrogenase inhibitors

Compositions and treatment for diabetic complications

Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications

Substituted oxoophthalazinyl acetic acids and analogs thereof

Sorbitol dehydrogenase inhibitors

1H-indazole-3-acetic acids as aldose reductase inhibitors

Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors

Processes and intermediates for the preparation of oxophthalazinyl acetic acids having benzothiazole or other heterocyclic side chains

Pyridazinone aldose reductase inhibitors

1H-indazole-3-acetic acids as aldose reductase inhibitors

Sorbitol dehydrogenase inhibitors

Method of reducing tissue damage associated with non-cardiac ischemia

Triazine compounds useful as sorbitol dehydrogenase inhibitors

Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors

Treatment for diabetic complications

Azacyclic-heterocyclic compounds as angiotension II receptor antagonists

Certain chlorination process for preparing 2-chloro-1,1,1-(C1 -C6)

Sorbitol dehrydrogenase inhibitors

Sorbitol dehydrogenase inhibitors

Therapies for tissue damage resulting from ischemia

Process for preparing chloromethyl thiazoles or oxazoles, and intermediates for use therein

Esters of quinoxaline-1,4-dioxides

Pyrroloquinoline and pyrrolophenothiazine carboxamides and related compounds

Method of reducing tissue damage associated with ischemia

Compositions and treatment for diabetic complications

THETIS PHARMACEUTICALS LLC

Tri-salt form of metformin

Tri-salt form of metformin

Compositions and methods relating to ionic salts of peptides

Lipid-lowering antidiabetic agent

Lipid-lowering antidiabetic agent

Lipid-lowering antidiabetic agent

Tri-salt form of metformin

UNIV COLUMBIA

Aldose reductase inhibitors and uses thereof

Aldose reductase inhibitors and uses thereof

Aldose reductase inhibitors and uses thereof

Aldose reductase inhibitors and uses thereof

Aldose reductase inhibitors and uses thereof

Aldose reductase inhibitors and uses thereof

INDIGENE PHARMACEUTICALS INC

Antidiabetic agent for control of diabetic hyperglycemia and diabetic complications

MYLARI BANAVARA L

Metformin derivatives for treating diabetes and diabetes complications